HighVista Strategies’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

HighVista Strategies’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-69,744	Closed	-$465K	–	153
2023 Q3	$465K	Buy	+69,744	New	+$580K	0.22%	116
2022 Q4	–	Sell	-43,836	Closed	-$339K	–	132
2022 Q3	$339K	Buy	+43,836	New	+$372K	0.19%	89

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HighVista Strategies's PNT Position: Q4 2023 in Review

HighVista Strategies sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 69,744 shares — an estimated $465K sold.

HighVista Strategies first reported a position in PNT in Q3 2022 and held it in 2 quarters. The position peaked at $465K in Q3 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

HighVista Strategies reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
HighVista Strategies sold 69,744 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $465K.
HighVista Strategies first reported a position in POINT Biopharma Global Inc. Common Stock in Q3 2022 and held it in 2 quarters.
HighVista Strategies's POINT Biopharma Global Inc. Common Stock position peaked at $465K in Q3 2023.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on HighVista Strategies's 13F filing for Q4 2023, filed 14 Feb 2024.